Markets

Aduro BioTech (ADRO) Looks Good: Stock Moves 8% Higher

Aduro BioTech, Inc.ADRO was a big mover last session, as the company saw its shares rise 8% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $27.05-$32.23 in the past one-month time frame.

In the last 30 days, the company has seen two upward estimate revisions but the Zacks Consensus Estimate moved lower, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Aduro BioTech currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked med-biomed/gene stock is Achillion Pharmaceuticals, Inc. ACHN , which sports a Zacks Rank #1 (Strong Buy).

Is ADRO going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ACHILLION PHARM (ACHN): Free Stock Analysis Report

ADURO BIOTECH (ADRO): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ADRO

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More